Genomenon CEO to Present at 2020 Digital Medicine & Medtech Showcase

Leveraging A.I. and Genomics to Drive Rare Disease Drug Development

  United States, Michigan, Ann Arbor - 01/07/2020 (PRESS RELEASE JET)

Ann Arbor, Michigan – January 7, 2020 – Genomenon®, home of the Mastermind® Genomic Search Engine, announced its participation at the 2020 Digital Health & Medtech Showcase being held in San Francisco, California January 13th - 15th, 2020 in parallel with the Biotech Showcase™ 2020 and the 38th annual J.P. Morgan Healthcare Conference. 

Mike Klein, Genomenon’s CEO, will be presenting, “Leveraging A.I. and Genomics to Drive Rare Disease Drug Development” on Wednesday, January 15th, 2020 at 11:45 a.m. at the Parc 55 San Francisco hotel. 

Genomenon is a precision medicine organization whose mission is to ensure that every rare disease patient is accurately diagnosed and properly treated. With over 7,000 rare diseases impacting more people combined than cancer and a $262B orphan drug market targeting rare diseases, Genomenon delivers the genomic tools and data needed to diagnose and treat the genetic drivers of each rare disease.

“I'm looking forward to being in San Francisco and presenting at the Digital Medicine & Medtech Showcase.” said Mike Klein, “Mastermind is a game-changer for clinical diagnostic labs and pharma companies that diagnose and treat rare disease.”

About Genomenon

Genomenon connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases.

Our flagship product, the Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield and assure repeatability in reporting genetic testing results.

We license Mastermind Curated Genomic Datasets to pharmaceutical and bio-pharma companies to inform precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.

For more information, visit Genomenon.com

About Digital Medicine & Medtech Showcase at Biotech Showcase

At the intersection of technology and medicine, the Digital Medicine & Medtech Showcase offers more than 70 dedicated company presentations and 500+ attendees exclusively from the digital medicine and medtech sectors. 

The event includes three days of networking opportunities, curated presentations and specialized sessions. These program elements create a forum for innovative digital medicine and medtech companies to plan for successful partnerships and evaluate growth prospects in a shifting healthcare market.